Back
Apollo Asset Management, Inc. Vs. Akero Therapeutics Industry Stock Comparison
Buy
53
APO
Apollo Asset Management, Inc.
Last Price:
$138.11
Seasonality Move:
3%
Buy
66
AKRO
Akero Therapeutics
Last Price:
$52.94
Seasonality Move:
26.74%
Buy
53
Apollo Asset Management, Inc. (APO)
is a Buy
Is Apollo Asset Management, Inc. a Buy, Sell or Hold?
-
The current Apollo Asset Management, Inc. [APO] share price is $135.62. The Score for APO is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
APO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $54.52. The Score for AKRO is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APO Stock Price Chart
What is Apollo Asset Management, Inc.'s stock price today?
-
The Apollo Asset Management, Inc. share price today is $135.62Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APO is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $54.52Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
APO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.54 | Sell |
Relative Strength Index (14 RSI): | 54.17 | Buy |
Chaikin Money Flow: | 1953600 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (129.36 - 140.32) | Buy |
Bollinger Bands (100): | (127.17 - 157.97) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.33 | Buy |
Relative Strength Index (14 RSI): | 70.35 | Buy |
Chaikin Money Flow: | 708985 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.73 - 51.79) | Buy |
Bollinger Bands (100): | (35.84 - 51.64) | Buy |
APO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 131.93 | Buy |
20-day SMA: | 135.16 | Buy |
50-day SMA: | 131.61 | Buy |
200-day SMA: | 144.22 | Sell |
8-day EMA: | 132.98 | Buy |
20-day EMA: | 133.41 | Buy |
50-day EMA: | 135.23 | Buy |
200-day EMA: | 137.93 | Sell |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.8 | Buy |
20-day SMA: | 47.39 | Buy |
50-day SMA: | 42.93 | Buy |
200-day SMA: | 36.38 | Buy |
8-day EMA: | 52.61 | Buy |
20-day EMA: | 49 | Buy |
50-day EMA: | 45.35 | Buy |
200-day EMA: | 38.09 | Buy |
Apollo Asset Management, Inc. Earnings Growth & APO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.32 per share, an increase this year of $0.67 per share, and an increase next year of $1.61 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
Apollo Asset Management, Inc. Technical Analysis
May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |